Melinda L. Telli

116 papers and 4.7k indexed citations i.

About

Melinda L. Telli has authored 116 papers that have received a total of 4.7k indexed citations. This includes 90 papers in Oncology, 45 papers in Cancer Research and 39 papers in Molecular Biology. The topics of these papers are PARP inhibition in cancer therapy (33 papers), HER2/EGFR in Cancer Research (26 papers) and Advanced Breast Cancer Therapies (24 papers). Melinda L. Telli is often cited by papers focused on PARP inhibition in cancer therapy (33 papers), HER2/EGFR in Cancer Research (26 papers) and Advanced Breast Cancer Therapies (24 papers) and collaborates with scholars based in United States, Germany and United Kingdom. Melinda L. Telli's co-authors include James M. Ford, Shaveta Vinayak, Allison W. Kurian, Ronald Witteles and Funda Meric‐Bernstam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation

In The Last Decade

Rankless by CCL
2025